Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Similar documents
Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

O N C E A DAY. In this leaflet FOR WOMEN

v MM 130.2MM FOR WOME N O N C E A D AY

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

WOMEN'S Regaine EXTRA STRENGTH

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Hair Loss Treatment Regular Strength (Minoxidil)

Daktacort 2% / 1% w/w cream

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Occlusal 26%w/w cutaneous solution salicylic acid

Retin-A 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Eumovate Cream clobetasone butyrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Dermovate Scalp Application clobetasol propionate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Package Leaflet: Information for the User

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Dermovate Scalp Application clobetasol propionate

What is in this leaflet 1. What Dalacin Cream is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

DP Fusidic Acid Cream

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

Eumovate Ointment clobetasone butyrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

ISOTREX GEL Isotretinoin 0.05% w/w

Dermovate Ointment clobetasol propionate

PATIENT INFORMATION LEAFLET. Timodine Cream

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Dermovate Ointment clobetasol propionate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

1 What Gyno-Daktarin cream is and what it is used for

Minoxidil. Hair Regrowth Treatment. Introducing Our New Product. Scalp-Friendly Formula. for Thinning Hair or Hair Loss HAIR CARE FOR MEN AND WOMEN

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

ACETOCAUSTIN 0,5 ml, Cutaneous solution

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Dalacin V Cream Clindamycin phosphate

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

TUGAIN MEN Solution (Minoxidil 5% + Finasteride 0.1%)

Daivobet 50/500 gel Dye-vo-bet

Information PROPECIA Finasteride 1mg Tablet

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

CONSUMER MEDICINE INFORMATION

SIGMACORT cream and ointment

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

A guide for patients who have been prescribed Stelara

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

SAFETY DATA SHEET STP BRAKE PARTS CLEANER

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

M A T E R I A L S A F E T Y D A T A

EUMOVATE Clobetasone butyrate 0.05% w/w cream

SAFETY DATA SHEET according to EC directive 2001/58/EC DILUENTE AUTOREFINISH.MEDIUM

MyStelara. For patients who have been prescribed Stelara

SAFETY DATA SHEET RED GLOSS PAINT

SAFETY DATA SHEET Sole Juice Ltd - Digi-Coat Clear Sublimation Coating DC- SC400ml Aerosol

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Patient Information Leaflet. Dermal Filler

marathon machinery aerosol

SAFETY DATA SHEET CFC FREE TAPE HEAD CLEANER

SAFETY DATA SHEET CONTACT TREATMENT GREASE AEROSOL*

MEDI-SWAB Skin Cleansing Swabs

Product Name: SCOTTS SCREEN WASH Creation Date: 10/10/12 CONCENTRATE Replaces: 21/07/11

Female pattern hair loss

M A T E R I A L S A F E T Y D A T A

Psoralen Tablets (Methoxypsoralen)

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Safety Data Sheet 1. IDENTIFICATION 2. HAZARDS IDENTIFICATION

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

SAFETY DATA SHEET SOLVENT CLEANER AEROSOL

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

SAFETY DATA SHEET WINSOR & NEWTON LIQUIN LIGHT GEL

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL CREAMY WASH. Benzoyl Peroxide Creamy Wash 4%

SAFETY DATA SHEET according to EC directive 2001/58/EC INDURITORE EC-GREEN

DON T LET HAIR LOSS TANGLE YOU UP: DERMATOLOGISTS CAN IDENTIFY COMMON HAIR DISORDERS AND OFFER SOLUTIONS

CRC Industries UK Ltd. Castlefield Industial Estate, Wylds Rd, Bridgwater, Somerset, UK, TA64DD Tel.: (+44)(0) Fax: (+44)(0)

Transcription:

Package leaflet: Information for the user Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam Minoxidil Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if your symptoms worsen or do not improve after 4 months. In this leaflet: 1. What Regaine Foam is and what it is used for 2. What you need to know before you use Regaine Foam 3. How to use Regaine Foam 4. Possible side effects 5. How to store Regaine Foam 6. Content of the pack and other information 1. What is and what it is used for Regaine contains minoxidil. Minoxidil regrows hair and stabilizes hair loss in men with a receding hairline and crown balding by revitalization of hair follicles. Regaine is used to treat men with common hereditary hair loss (also called androgenetic alopecia). It is to be used only on the scalp (head) 2. What you need to know before you use Regaine Foam Do NOT use Regaine Foam if you - are allergic to minoxidil or any of the other ingredients of this medicine (listed in section 6). Warning and precautions Talk to your doctor or your pharmacist before using Regaine if you - suffer from heart disease including abnormal heart rhythms or rates, angina or chest pains and/or circulation disorders. Some patients have experienced changes in hair colour and texture with this medicine.

Increased hair shedding (small scalp skin layers that fall off) may occur during the initial 2 to 6 weeks of treatment. This is a sign that it works and that new hairs are replacing old hairs).this stops within a couple of weeks. If shedding persists, stop using Regaine and consult with your doctor. Accidental ingestion may cause serious cardiac adverse events. Therefore this product has to be kept out of the reach of children. You should not use Regaine if the pattern of your hair loss differs from a receding hair line and crown balding you have no family history of hair loss your hair loss is sudden and/or patchy you do not know the reason for your hair loss your scalp is red, inflamed, irritated or painful.! Regaine Foam is EXTREMELY FLAMMABLE! Avoid fire, flame, or smoking during and immediately following application. Children and adolescents Regaine should not be used by children and adolescents below 18 years. Other medicines and Regaine Foam Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Regaine should not be used concomitantly with other medications applied topically on the scalp. Other cosmetic hair products and Regaine Use of shampoo during treatment You should use a mild shampoo in conjunction with using Regaine. Your scalp must be dry before you apply Regaine. Use of hair grooming products during treatment For best results, Regaine should be allowed to soak into the scalp before using any styling products. Apply Regaine first, and then apply your styling products as usual. Do not mix with other preparation for use on the scalp. Advice about hair colour or perming There is no available information if these treatments change the effect of Regaine. However, to avoid possible scalp irritation, you should make sure all of the Regaine has been washed off the hair and scalp before using these chemicals. Also, you should tell your hair care professional that you are using Regaine. Pregnancy, breastfeeding and fertility Regaine Foam is not for use by women. This medicine is not recommended during pregnancy, lactation or when trying to conceive. Driving and using machines It is not expected that Regaine Foam would interfere with your ability to drive or operate machinery.

Regaine Foam contains: Ethanol (alcohol) which will cause burning and irritation if you get it in your eye. If you get Regaine Foam in your eye, mouth or a cut or damaged skin, wash the area well with plenty of cool tap water. Butylated hydroxytoluene which may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes. Cetyl alcohol and stearyl alcohol which may cause local skin reactions (e.g. contact dermatitis). 3. How to use Regaine Foam Always use Regaine Foam exactly as stated in this package leaflet or as your doctor or your pharmacist have told you. You should check with your doctor or pharmacist if you are not sure. Use this foam twice a day to achieve and maintain the desired effect on hair growth. This foam is for use on the scalp only. Do NOT apply on other parts of the body. Make sure to apply the foam directly to the scalp. Avoid contact with the eyes. If you get the foam in your eyes, rinse your eyes immediately with plenty of cool tap water. Before using the foam: Your hair and scalp should be dry. How to apply the foam: Apply a dose of 1 g (equivalent to the volume of half a capful) to the hair loss area twice a day. To open the container, match the arrow on the can ring with the arrow on the cap. Remove the cap (Figure 1). The foam may begin to melt on contact with warm skin. If your fingers are warm, rinse them in cold water first. Be sure to dry them thoroughly before handling the foam. Hold the can upside down and press the nozzle to dispense the foam product onto your fingertips (Figure 2). The total amount of foam applied should not be more than 1g (equivalent to the volume of half a capful). Using your fingers, massage the foam lightly into the affected areas of the scalp (Figure 3) and then wash your hands immediately after applying the foam. After each use, close the container by snapping the cap back onto the can. figure 1 figure 2 figure 3

Duration of use with Regaine It takes time to regrow hair. Results may occur at 2 months with twice a day usage. For some men you may need to use this product for at least 4 months before you see results. What to expect while using Regaine Foam In the first couple of months, some users may experience increased hair shedding after using this foam for the first time. This can be a sign that Regaine is working. This temporary increase in hair shedding generally occurs between 2 and 6 weeks after beginning of treatment and then subsides. If increased shedding continues after 6 weeks, see your doctor. Hair is usually soft, downy and colourless. After further use, the new hair should be the same colour and thickness as the other hairs on your head. Since hair grows slowly, Regaine takes time to work. Results may be seen in 2-4 months with twice a day use. If there s no hair regrowth after 4 months, then stop using Regaine The amount of hair re-growth is different for each person. This product will not work for all men. If you use more Regaine Foam than you should Follow directions for use. Do not use more than 2 g (equivalent to the volume of one capful) in a day, and do not use more than twice a day. Your hair will not regrow any quicker and you will not get any better effect if you use more or if you use it more often. If a child swallows any Regaine Foam, take him/her to a hospital immediately (with the Regaine Foam can if possible, as the doctor may like to have some idea of how much the child has swallowed). If you forget to use Regaine Foam Do not worry if you miss one or two applications, just continue to use the product as though you had not missed the dose. Do not put double the amount on your scalp if you forget an application. If you stop using Regaine Foam If you stop using the foam, regrown hair may fall out and your scalp will likely return to its former state within 3-4 months. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, Regaine Foam can have side effects, although not everybody gets them. If you experience any of the following, STOP using the foam and tell your doctor as soon as possible: Swollen hands or feet, shortness of breath(uncommon: may affect up to 1 in 100 people) Persistent local redness or rash. (uncommon: may affect up to 1 in 100 people) Faintness or dizziness.(not known: frequency cannot to be estimated from avilable data) Rapid heart beat. (rare: may affect up to 1 in 1000 people) Chest pain.(rare: may affect up to 1 in 1000 people) Low blood pressure. (uncommon: may affect up to 1 in 100 people)

Sudden unexplained weight gain. Other side effects which may occur: Common side effect (may affect up to 1 in 10 people) which may occur is Headache. High blood pressure Uncommon side effects (may affect up to 1 in 100 people) which may occur are: Itching, excessive hair growth, acne, irritated skin, inflammatory skin disorders causing redness and itching and breathing discomfort or difficulty in breathing, pain, blistering, bleeding and ulceration. Scalp irritation such as local redness, itching, dryness, flaky skin have all been reported. This may be due to the other ingredients in the product - hydroxybutylated toluene, cetyl alcohol and/or stearyl alcohol. This is usually only a temporary effect, but if it is persistent, stop using this product. Unwanted non-scalp hair has occasionally been reported. Always wash your hands thoroughly after application and if you accidentally apply the foam to parts of the body other than the scalp, rinse thoroughly with plenty of water. Temporary hair loss may occur during the first 2-6 weeks of use. This is likely to be as a result of a change within the growth cycle and it should stop within a couple of weeks. If this hair loss continues for longer than 2 weeks, stop using the product and talk to your doctor. Change in hair colour and/or texture may occur. If this happens stop using Regaine Foam. Not known side effect (frequency cannot be estimated from the available data) Dizziness, eye irritation, nausea, and vomiting, swelling of the skin, the face or head; redness, itching or irritation of the skin, mouth, tongue or neck, and tightness of the throat. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail:medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Regaine Foam Keep this medicine out of the sight and reach of children. Danger extremely flammable aerosol: Pressurised container: May burst if heated. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not spray on an open flame or other ignition source. Do not pierce or burn, even after use. Protect from sunlight and keep Can in the outer packaging. Do not expose to temperatures exceeding 50 C. Do not use Regaine Foam after the expiry date which is stated on the base of the can after the letters EXP. The expiry date refers to the last day of that month. Exposure of the container and contents to naked flame should be avoided during disposal.do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Content of the pack and other information What Regaine Foam contains The active substance is minoxidil Each gram of cutaneous foam contains 50 mg of Minoxidil (5 % w/w). The other ingredients are ethanol anhydrous, purified water, Butylhydroxytoluene (E321), lactic acid, citric acid anhydrous, glycerol, cetyl alcohol, stearyl alcohol, polysorbate 60 and propane/ butane/ isobutane (propellant) What Regaine Foam looks like and contents of the pack This medicinal product is presented as cutaneous foam in a pressurised container with a child-resistant polypropylene overcap. The foam is white to yellowish in colour and unscented. It is presented in a 60 g (equivalent to 73 ml) aerosol can. The can contains enough for 1 month of treatment. Packs contain 1 or 3 cans. Not all pack sizes may be marketed. Product Authorisation Holder: McNeil Healthcare (Ireland) Ltd. Airton Road, Tallaght Dublin 24, Ireland Manufacturer: Janssen Cilag Domaine de Maigremont, 27100, Val de Reuil, France This medicinal product is authorised in the Member States of the EEA under the following names: Finland, Norway, Sweden: Rogaine Austria, Belgium, Denmark, Ireland, Iceland, Netherlands, Portugal, Romania, Slovenia, Spain: Regaine France: Alostil This leaflet was last revised in To be completed upon approval